Increase/Decrease in Cash: The total change in cash for the company over the given period.
ReNeuron Group (RNUGF) had Increase/Decrease in Cash of $-1.36M for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$7.27M |
|
$0.33M |
|
$0.86M |
|
$8.13M |
|
$4.83M |
|
$0.24M |
|
$0.24M |
|
$5.07M |
|
$3.06M |
|
$2.83M |
|
$3.06M |
|
57.15M |
|
| Cash Flow Statement Financials | |
$-2.66M |
|
$1.41M |
|
$-0.10M |
|
$7.79M |
|
$6.42M |
|
|
Increase/Decrease in Cash |
$-1.36M |
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|